Pharmacist Cardiovascular Podcast 30m

Dyslipidemia remains a major contributor to cardiovascular disease, and pharmacists play a key role in optimizing therapy and improving outcomes. This episode reviews recent updates in guidelines, pharmacologic options, and practical counseling tips for supporting patients with lipid disorders. Tune in to strengthen your clinical impact and support long-term health for the patients you serve. 

Learning Objectives

Upon successful completion of this course, learners should be able to:
1. Describe current guidelines and evidence-based pharmacologic options for managing dyslipidemia.
2. Identify key counseling strategies pharmacists can use to support adherence and improve lipid-related outcomes. 

Faculty

Joshua Davis Kinsey, PharmD

VP, Education
CEimpact

Disclosures:

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Janelle Ruisinger, PharmD, FAPhA

Clinical Professor
The University of Kansas School of Pharmacy

Disclosures:

Janelle Ruisinger is a co-investigator with Amgen. All relevant financial relationships have been mitigated.

Course Details